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 ABSTRACT 
 
INTRODUCTION: - 
 
Guillain-Barre syndrome is a common cause of acute and severe generalised neuropathic 
weakness. Nerve conduction studies are the most important diagnostic tests. It is classified 
into various subtypes based on the electrophysiological characteristics. Prolonged distal 
motor latency and conduction block are features of AIDP. The characteristic 
electrophysiological features of AMAN are reduced amplitude or absence of distal 
compound muscle action potentials indicating axonal degeneration. Recently there is 
growing recognition of reversible conduction blocks in AMAN. 
 
OBJECTIVES: - 
To evaluate the utility of multiple segment stimulation of motor nerves, proximal 
conductions and serial nerve conduction studies in patients with Guillain Barre syndrome.  
 
METHODS: - 
Ten patients admitted within the first week of onset of weakness diagnosed with GBS were 
included in the study and underwent multiple segment stimulation of upper limb motor 
nerves as well as proximal conductions as part of the electrophysiological study and were 
followed up with serial nerve conduction study every week till they improved by one 
Hughes grade or till 4 weeks. The data was analysed using the SPSS software and the chi – 
square test was used for analysis of significance. 
RESULTS: -  
 H-reflex abnormalities and prolonged / absent F-wave latencies were the most common 
electrophysiological abnormalities in the nerve conduction study done in the first week of 
illness. Multiple segment stimulation of motor nerves showed a higher yield of detecting 
conduction blocks in the first week especially across the entrapment sites. Two patients 
who had conduction blocks in the multiple segment stimulation in the first study and 
fulfilling the criteria for AIDP, had completely in-excitable motor nerves in the second 
conduction done one week later with evidence of active denervation on needle EMG 
suggestive of an axonal pathology.   
 
CONCLUSION: - 
Multiple segment stimulation helps in the detection of a higher percentage of conduction 
blocks in patient with GBS. Serial nerve conductions are important as there can be change 
in the electrophysiological classification with time. Some of the motor nerves showing 
conduction blocks may be on follow up show evidence of axonal degeneration and may 
indicate an electrophysiological feature of acute motor axonal neuropathy. 
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Guillain-Barre Syndrome (GBS) is a clinical condition that is characterized by rapidly 
evolving symmetrical limb weakness, loss of tendon reflexes, absent or mild sensory signs 
and variable autonomic dysfunction. After the eradication of poliomyelitis, GBS is the 
most common cause of acute flaccid paralysis.1 Initially the term GBS was used 
synonymously with the term Acute inflammatory demyelinating polyradiculoneuropathy 
(AIDP). However over the years with the discovery of newer antibodies and distinct 
pathophysiological mechanisms being elucidated, the clinical spectrum has widened. There 
has been a change in the taxonomy to include three major subgroups also like - Acute 
motor axonal neuropathy (AMAN), Acute motor sensory axonal neuropathy (AMSAN) 
and Miller–Fisher syndrome.1 A few other variants have also been described. There are 
geographical differences in the incidence of the various subtypes and an inter-play of 
microbial and host factors determine the susceptibility to develop the clinical disease. All 
these make GBS a phenotypic syndrome. The role of antecedent infections resulting in 
immuno- targeting of the specific components of the peripheral nerve have been better 
studied and there has been a paradigm shift in the knowledge of the target of the 
autoimmune process from the myelin related epitopes to the axolemma in the various 
subtypes.2    
Nerve conduction studies are the most important ancillary diagnostic test and have helped 
in characterizing the various subtypes as AIDP, AMAN, AMSAN are difficult to 
distinguish on clinical grounds. The electrodiagnostic yield depends on the duration of the 
disease and the timing of the study. During the first day or two it may be difficult to 
identify the neurophysiological abnormalities. The electrophysiological abnormalities may 
not be sufficiently widespread for definite diagnosis in the first week,3 however early 
diagnosis is important, because treatment arrests the progression of the disease, reduces the 
time/obviates the need for receiving mechanical respiratory assistance and lessens the 
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overall morbidity. Electrodiagnostic (EDX) studies in AIDP often show evidence of 
patchy demyelination, manifested as delayed distal motor latencies, conduction block, 
slowed motor conduction velocities (CVs) and dispersed responses. The diagnosis of 
AMAN is currently based on the absence of demyelinating features and reduction in the 
distal compound muscle action potential amplitude.4 However, studies with serial nerve 
conduction recordings have shown that GBS patients with anti- ganglioside antibodies 
show in addition to axonal features, conduction block and conduction slowing without 
development of temporal dispersion and prolonged F- wave latencies which are restored in 
the subsequent conduction study. It was thought that these findings are incompatible with 
demyelination and remyelination and thereby indicated that AMAN is characterized not 
only by axonal degeneration but also by “reversible conduction failure” possibly induced 
by antiganglioside antibodies at the axolemma of the node of Ranvier.5 Most of the 
published studies till date are cross sectional studies and there is paucity of studies from 
India which have looked at serial conductions in Guillain – Barre syndrome.  
The goal of this study was to determine if there are characteristic electrodiagnostic findings 
within the first week using multiple segment stimulation of motor nerves including 
proximal segment stimulation to understand if there are early patterns that are suggestive 
of GBS and also to follow up these patients with repeat conductions to investigate how 
serial recordings changed the initial classification.  
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Guillain-Barre Syndrome is an acute onset immune mediated disorder of the peripheral 
nervous system. It is the most frequent cause of post infectious neuromuscular weakness 
worldwide. 6   
HISTORICAL PERSPECTIVE  
The first description of the clinical features of Guillain Barre Syndrome was by Landry in 
1859. Eichorst, in 1877 and Leyden in 1880, described the pathological findings of 
lymphocytic inflammation of the nerve in some cases of peripheral neuropathy. The 
description of the CSF findings characteristic of the disease was in 1916 by three French 
neurologists - Georges Guillain, Jean- Alexandre Barre and Andre Strohl in two soldiers 
who developed acute areflexic paralysis followed by gradual recovery. The CSF in these 
patients showed a raised protein and a normal cell count.4 Over time it has become clear 
that this clinical picture now called Guillain-Barre Syndrome can have different 
pathological subtypes and is related to other less common disorders.  
The three common subtypes are acute inflammatory demyelinating 
polyradiculoneuropathy (AIDP)7,8, acute motor axonal neuropathy (AMAN) where the 
neurological deficit is purely motor 9,10,11,12 and acute motor and  sensory axonal 
neuropathy (AMSAN), where sensory fibers are also affected. 13A review of literature has 
shown that in North America and Europe typical patients usually have AIDP as the 
underlying subtype and only 5 % have axonal subtypes of the disease. In contrast, axonal 
forms of the syndrome constitute 30 - 47% of cases as per studies from northern China, 
Japan and central and south America.10, 11, 12 The neuromuscular weakness in AIDP and the 
axonal subtypes may affect all four limbs and the cranial nerves and respiration.14,15 AIDP 
patients, especially severe cases with respiratory failure tend to have more autonomic 
involvement than AMAN. Another subtype described are cases of acute dysautonomia 
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without involvement of the somatic nerves presumed to have an inflammatory or possibly 
autoimmune etiology. 16 
Guillain-Barre Syndrome and related disorders and typical antiganglioside 
antibodies: - 2 
 Antibodies 
Acute inflammatory demyelinating polyradiculoneuropathy 
(AIDP) 
Unknown 
Acute motor axonal neuropathy (AMAN) GM1, GM1b, GD1a 
Acute motor and sensory axonal neuropathy (AMSAN) GM1,GM1b,GM1a, 
GalNac-GD1a 
Acute sensory neuropathy GD1b 
Acute pan dysautonomia   
 Regional variants  
           Fisher’s syndrome 
          Oropharyngeal 
 
GQ1b, GT 1a 
GT1a 
Overlap  
         Fisher’s syndrome / Guillain –Barre syndrome    
overlap 
GQ1b, GM1,GM1b, 
GD1a, GalNac-GD1a 
 
In 1956, C Miller Fisher described a clinical triad of acute opthalmoplegia, areflexia and 
ataxia and postulated that this set of features were a form of Guillain Barre Syndrome. 
Now known as Fisher’s syndrome, this subset of patients may have facial and lower 
cranial nerve involvement. Over lap forms with limb weakness and respiratory 
involvement are not rare. Also encountered are Formes- fruste with various combinations 
of opthalmoplegia, facial palsy, bulbar palsy and sensory neuropathy.17 
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Epidemiology  
World wide incidence  
The reported incidence of typical Guillain-Barre syndrome is relatively uniform 
throughout the world and ranges between 0.6 and 4 cases per 100000 per year, but the 
most recent best estimate of the overall incidence of GBS was between 1.1/100,000/year 
and 1.8/100,000/year.18 All reports agree that men are 1.5 times more likely to be affected 
than women. Fisher’s syndrome is much less common and an incidence of 0.1 per 100000 
has been reported by Italian researchers. European and North American data show that the 
incidence of GBS increases with age after 50 years from 1.7/100,000/year to 3.3 /100,000 / 
year. 19,20, 21, 22 
 In China, the reported incidence in children is about the same and much less in adults as 
elsewhere, giving an overall annual incidence of 0.66 per 100000 for all ages.23 Similar 
studies from other regions report that the incidence of Guillain-Barre syndrome has been 
relatively stable over successive years. Most cases are sporadic, but there are reports of 
small clusters occurring in association with outbreaks of bacterial enteritis caused by 
contaminated water and campylobacter jejuni has been implicated in cases of summer 
epidemics in northern China.23  
Preceding infection detected serologically in two large series of patients with GBS:- 
 Netherlands 22 
[1987-1996] (n=476) 
North America and  24 
Europe [1993-95] (n=383) 
Campylobacter jejuni        32          23 
Cytomegalovirus      18           8 
Epstein – Barr Virus        7           2 
Mycoplasma pneumoniae       9         Not tested 
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All series report that two thirds of patients have had an infection within the previous 6 
weeks, most commonly a flu-like illness or gastroenteritis. 24 The responsible organism is 
often not identified, but a range of bacteria and viruses have been implicated in various 
observational and case control studies. The infection may elicit an immune response that 
cross reacts with axolemmal or Schwann cell antigens, thus damaging the peripheral 
nerve.24 
The possibility of Guillain-Barre syndrome being triggered by certain immunisations in 
susceptible individuals was raised following reports of a slightly increased incidence after 
swine-flu vaccines were given in USA in 1976. 25,26,27 Other influenza vaccines have not 
been associated with the same risk and reports show that between 1990 and 2003 there has 
been a steady decline in the number of cases of Guillain-Barre syndrome associated with 
influenza vaccine.28 Other conventional vaccines have not been associated with a 
significant risk despite many individual case reports.29 However, rabies vaccine that 
contain sheep brain material is associated with Guillain- Barre syndrome in about one in 
1000 cases.30 
CLINICAL FEATURES AND DIAGNOSIS - 
The onset of Guillain-Barre syndrome is usually abrupt with distal and relatively 
symmetrical onset of paraesthesias. Progressive limb weakness usually accompanies or 
quickly follows the sensory disturbances. A definite date of onset of symptoms is 
identified by the patients. Usually there is a rapid progression of weakness with 
approximately 50% of patients reaching the clinical nadir by 2 weeks and more than 90% 
reach by 4 weeks. By current diagnostic criteria the duration of progression to clinical 
nadir is defined as less than 4 weeks.31 It is possible to differentiate between subacute and 
chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), in which the onset 
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phase lasts 4 to 8 weeks 32, 33 or more than 8 weeks 34 respectively, only retrospectively. 
When patients have recurrent attacks of Guillain-Barre syndrome such cases can overlap 
with CIDP resulting in difficulties in classification.35, 36 There are reports of one or more 
episodes of worsening after initial improvement in approximately  8% and 16% of patients 
presenting with a Guillain-Barre like illness. Data from one study showed that  patients 
who deteriorated more than 9 weeks after the onset of their neuropathy or who had more 
than two treatment-related fluctuations were more likely to develop CIDP.37 
Approximately 80 to 90% of patients with GBS become non-ambulatory during the course 
of their illness.38,39 Pain is prominent complaint in approximately 50% of patients.40 
Neurological examination will demonstrate relatively symmetrical weakness distally and 
often proximal as well. In the early phase of disease, sensory examination is often 
normal.41 Wide spread areflexia or hyporeflexia is the rule especially in AIDP. Cranial 
nerve involvement, usually in the form of facial or pharyngeal weakness as well as 
diaphragmatic weakness due to phrenic nerve involvement is seen.42 Mechanical 
ventilation is required in approximately one third of hospitalized GBS patients because of 
respiratory muscle or oropharyngeal weakness.43,44,45Autonomic disturbance is 
documented in more than 50%, more common in patients with AIDP than in AMAN.46,47 
The usual manifestation is tachycardia but more serious dysfunction, including life-
threatening arrhythmias, hypotension, hypertension  and gastrointestinal motility 
dysfunction may occur.48,49 
The ancillary tests supportive for diagnosis of GBS includes CSF analysis and 
electrodiagnostic testing, both of which may be normal in the early phase of GBS.38 The 
limitations of the above tests in the early phase combined with the importance of prompt 
treatment of GBS underlines the importance of clinical diagnosis based solely on history 
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and examination. Reports show that an elevated CSF protein concentration (with normal 
cell count) is only found on initial CSF analysis in ~50% of patients; while elevated CSF 
protein concentration occurs in more than 90% of patients at clinical nadir.41 There is 
routinely no reason to repeat the CSF analysis if the initial CSF is normal and clinically, if 
there is a reasonable degree of certainty about the diagnosis. CSF pleocytosis (> 10 cells) 
is not seen in GBS and possibilities to be considered in this scenario are those of – 
infectious causes like (HIV, CMV, Lyme) and other etiologies like sarcoid, carcinomatous, 
or lymphomatous polyradiculoneuropathy. 41 
The range of differential diagnosis is wide and it is imperative on the clinician seeing the 
patient, to recognise that the problem is an acute peripheral radiculoneuropathy. 
Differential diagnosis of acute flaccid paralysis:- 4 
Brainstem stroke 
Brainstem encephalitis 
Acute anterior poliomyelitis 
      • Caused by poliovirus  
      • Caused by other neurotropic viruses 
Acute myelopathy 
       • Space-occupying lesions  
      • Acute transverse myelitis 
Peripheral neuropathy 
       • Guillain-Barre syndrome  
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       • Post-rabies vaccine neuropathy 
       • Diphtheritic neuropathy 
       • Heavy metals, biological toxins or drug intoxication 
       • Acute intermittent porphyria 
       • Vasculitic neuropathy 
       • Critical illness neuropathy 
       • Lymphomatous neuropathy 
Disorders of neuromuscular transmission 
      • Myasthenia gravis  
      • Biological or industrial toxins 
Disorders of muscle 
      • Hypokalemia  
      • Hypophosphatemia 
      • Inflammatory myopathy 
      • Acute rhabdomyolysis 
      • Trichinosis 
  Channelopathies-   Periodic paralysis 
Immunopathologic and Electrophysiological correlates in Guillain-Barre syndrome 
subtypes:- 
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AIDP and the demyelinative conduction block- 
The pathologic picture classically described in AIDP is segmental demyelination with 
multifocal mononuclear cell infiltration throughout the peripheral nerves. The 
macrophages have been shown to invade and strip the myelin sheath denuding the axon. 
Macrophages are targeted to antigens on the surface of Schwann cells or myelin by 
activated T cells. They are the major acting components in the model of experimental 
autoimmune neuritis predominantly caused by T-cell mediated immunity against peptides 
from the myelin proteins.50 The role of humoral factors, like antibody and complement is 
also considered important in view of the therapeutic efficacy of plasma exchange which is 
presumably related to the removal of humoral factors, but not T cells.  
During plasma exchange, the cytokines produced by T cells are also removed, but their 
circulating half lives are only a few hours and the efficacy, if limited to this, would be 
short term. Recently, pathologic studies done at early stages of AIDP have identified 
vesicular myelin degeneration as a prominent process and demonstrated complement 
activated products on the outer surface of Schwann cells of myelinated fibers.51 Because of 
the background endoneurial staining, specific binding of immunoglobulin on the Schwann 
cell surface was not identified. It also showed extensive lymphocytic infiltrates and large 
numbers of foamy macrophages in the endoneurial space. The above findings suggest that 
the primary change in AIDP is binding of auto antibodies to unidentified targets at the ab-
axonal Schwann cell plasmalemma, with consequent activation of complement, although 
one cannot entirely abandon the T-cell-mediated hypothesis. The demyelination, especially 
at the early phase, may be limited to nerve roots and distal intramuscular nerves where the 
blood-nerve barrier is weak and later it may be widespread and extensive throughout the 
nerve length.51  
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Schwann cells proliferate and migrate into the lesion sites to remyelinate the denuded 
axons producing generally good recovery in AIDP. The axons may be affected in AIDP 
secondary to the pathological events of demyelination (so-called bystander injury), and in 
some instances significant axonal damage may develop influencing the residual disability 
and long-term outcome.51 Extensive electrodiagnostic examination is recommended in the 
diagnosis of GBS subtypes, which should include at least three motor nerves with multiple 
site stimulation and F-wave recordings, three sensory nerves and bilateral tibial H-reflex.  
The characteristic features of demyelination – remyelination are demonstrated in the 
electrophysiology study in AIDP:- 52 
• Reduced nerve conduction velocity 
• Prolonged distal motor latency (DML) 
• Prolonged or absent F-wave 
• Conduction block (CB), defined as an abnormal amplitude / area reduction of compound 
muscle action potential (CMAP) from proximal stimulation compared with the CMAP 
after distal stimulation 
• Excessive temporal dispersion which is characterized by an abnormal duration of CMAP. 
The duration of the disease determines the electro-diagnostic yield. In AIDP, the 
characteristic electrophysiological picture is usually demonstrable at 2- 3 weeks after 
onset. Because of the patchy nature of demyelination, in early AIDP, the nerve conduction 
studies may be normal (up to 13%) or non diagnostic.14 During the first day or two, it may 
be difficult to identify the neurophysiological abnormalities. Gordon et al,53 in a 
retrospective analysis of 31 patients with GBS  evaluated within seven days of onset of 
weakness, detected the following findings :- H-reflex was absent in 30 (97%), upper 
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extremity SNAP was of low amplitude or unrecordable in 19 (61%), F waves were 
abnormal in 25(84%), reduced CMAP in 22 (71%), prolonged distal latency in 20(65%), 
temporal dispersion in 18 (58%), slowed motor conduction velocity in 16 (52%) and 
conduction blocks in 4 (13%) patients. Definite diagnosis was possible in 17(58%) patients 
but not commonly until the fifth day. The above study highlighted that absent H-reflex was 
most sensitive for diagnosis of early GBS but it is not specific. Also abnormal upper 
extremity SNAPs’ with normal sural SNAPs’ and absent F-wave responses were 
characteristic of early GBS.53  Studies also showed that in the upper extremities conduction 
block is more frequent in nerve terminals, across the elbow and in the axillary to spinal 
root segments. This supports the hypothesis that certain regions, perhaps because of a 
relative deficiency of the blood–nerve barrier, may be more vulnerable.52 
 Patients’, early in the disease course or those with a mild form of the disease may not 
always meet the criteria for an abnormal study. Moreover, definitive assignment to a GBS 
subtype may be difficult when motor nerves are in-excitable. In such patients it is difficult 
to determine whether a non-recordable CMAP is due to distal conduction block or axonal 
degeneration. Reduced motor unit action potential recruitment with fast firing of motor 
unit potentials in seen in needle electromyography. Secondary axonal degeneration is 
responsible for the presence of spontaneous activity in a few muscles’, if seen. Markedly 
reduced amplitude of summated CMAPs’ of median, ulnar, peroneal and tibial nerves from 
distal stimulation has been associated with poor long-term prognostic outcome in several 
studies.52  
Thus in AIDP, conduction block due to acute demyelination and axonal degeneration 
secondary to demyelination are the electrophysiological correlates of muscle weakness.  
Prolonged distal motor latency, excessive temporal dispersion and reduced nerve 
conduction velocity are the characteristic correlates of the remyelinating phase. These 
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abnormalities may be associated with a reduced safety margin for impulse conduction. 
Physiologically they correlate with activity- dependent hyper polarization and conduction 
block occurring during sustained voluntary contraction.54 However, they are not the major 
determinants of muscle weakness. 
 Conduction block is defined as the failure of action potential propagation at a given site 
along a structurally intact axon.55 The leakage of current through the axon between the 
nodes of Ranvier is prevented by the myelin sheath which provides high impedance and 
low capacitance and also enables saltatory conduction of the nerve. Action current, 
through sodium channels at the activated nodes of Ranvier, produces inward ionic 
(sodium) current, which subsequently causes outward capacitive current at the next node to 
be excited (driving current). This depolarizes the nodal membrane to the threshold, 
opening the sodium channels and initiating another cycle of inward ionic current. Safety 
factor of transmission is defined as the ratio of driving current to threshold current. The 
safety factor is five or more in normal myelinated fibers. To assure conduction through an 
inter node it has to be more than one. The transmission of impulses is impaired by 
demyelination by changing the properties of para-nodal and inter-nodal membranes - 
increasing capacitance, decreasing resistance, thus dissipating the current over a larger 
area. Therefore, it takes more current and a longer time to depolarize the enlarged node to 
threshold with the result of an increased inter-nodal conduction time. The current becomes 
insufficient to depolarize the node to threshold as demyelination progresses and the safety 
factors falls below unity resulting in conduction block.55 
The activation of potassium channels that are normally localized in the para- nodal 
axolemma and exposed by para-nodal demyelination is another factor aggravating the 
block. The potassium channels are activated for repolarization, when the paranodal axon 
exposed by demyelination undergoes depolarization. This shortens the duration of the 
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active current through the node, thereby reducing the safety factor for transmission even 
more. Reduction of the CMAP amplitude on proximal stimulation versus distal stimulation 
occurs when conduction block affects an adequate number of axons in a nerve segment. 
Excessive temporal dispersion due to increased difference among the conduction times 
along axons, may result in abnormal reduction of proximal CMAP.55 
 Due to temporal dispersion, there are de- synchronization and phase cancellations between 
the positive and negative phases of the motor unit action potentials which compound the 
CMAP. Hence, strict electrophysiological criteria should be applied to distinguish ‘pure’ 
conduction block from an abnormal CMAP amplitude / area reduction due to excessive 
temporal dispersion. The above mentioned findings indicate that, in AIDP, acute 
segmental demyelination and CB due to an immune attack of myelin and Schwann cells 
are the pathologic and electrophysiological correlates of muscle weakness.55 
Acute motor axonal neuropathy and axonal degeneration - 
The reported frequency of acute motor axonal neuropathy (AMAN) varies around the 
world. It totals 4% of all GBS in a multi-center study including 11 Western countries, 7% 
in England56, 8% in India57, 22% in Israel58, 38% in Japan59, 38% in Mexico 60 and 65% in 
northern China.61 The onset of weakness in AMAN is abrupt, with rapid progressive 
ascending weakness clinically indistinguishable from AIDP.62 There is less frequent facial 
and extraocular muscles involvement. 63,64 The ‘Finger drop’ sign has been described in 
AMAN patients. In AMAN there are no sensory symptoms or signs and deep tendon 
reflexes may be preserved throughout the disease course. They may even be hyper-
excitable in the acute or recovery phase.65,66 AMAN has been epidemiologically associated 
with antecedent Campylobacter jejuni infection. In AMAN, autoantibodies to gangliosides 
GM1 and GD1a have been found in 40 % and 30% of patients, respectively.59 Studies have 
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demonstrated that the lipo-oligosaccharide of C. jejuni carry GM1- and GD1a-like 
structures and an animal model of AMAN has been produced by sensitization with such 
lipo-oligosaccharide.67,68 The above observations demonstrate that AMAN subsequent to 
C. jejuni infection is a true case of molecular mimicry.  
 
Figure 1- shows the role of C.jejuni with respect to the immunopathogenesis of AMAN and Miller 
Fisher syndrome - (reproduced with permission- Yuki; Journal of Neuro immunology 2009) 
The primary target for immune attack in AMAN is the axolemma in contrast to AIDP. 
Pathological changes ranging from minimal to severe wallerian-like degeneration with 
deposits of IgG and complement at the nodes of Ranvier have been seen in autopsy studies 
of AMAN patients.12 The presence of macrophages in the peri axonal space surrounding or 
displacing the axon, and even localized intra-axonally is a prominent feature. There is little 
or no evidence of demyelination or lymphocytic inflammation in AMAN. 
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 Reduced amplitude or absent distal CMAPs were the electrophysiological features firstly 
described in AMAN patients.62 From 1995 onwards, the proposed criteria for diagnosis of 
AMAN were the absence of demyelinating features, as derived from Albers and 
colleagues,69 and the decrease in distal CMAP amplitude to less than 80% of the lower 
limit of normal.61 The sensory nerve conductions including sensory action potential 
amplitude (SNAPs’) and somato-sensory evoked potentials (SSEP) are normal in 
AMAN.70,71  
On the contrary, electrophysiological evidence of involvement of sensory nerves has been 
reported in up to 80% of patients by the third week of illness in AIDP.69 Motor-point 
biopsy from an AMAN patient revealed denervated neuromuscular junctions but relatively 
preserved intramuscular motor axons. This indicates the possibility of very distal motor 
terminal damage.72 
 An abnormal amplitude reduction of proximal CMAP mimicking a demyelinative 
conduction block may be found in the early stage of AMAN. Serial conduction studies on 
the following days, may demonstrate that the amplitude of proximal CMAP equalizes to 
the distal CMAP without development of excessive temporal dispersion.72 
The progressive loss of excitability in nerve fibers undergoing axonal degeneration results 
in a length-dependent reduction of CMAP amplitude and can be interpreted as pseudo 
conduction block.73, 74 In acute axonal injury, the distal CMAP is greater than the proximal 
CMAP because, the axons distal to the lesion remain excitable and viable for days, 
whereas stimulation above the injury site cannot generate a potential capable of travelling 
through the lesion. The axonal in-excitability in the axon distal to the lesions progresses 
over days depending on the length of the nerve.74 
AMAN and reversible conduction failure – 
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The neurophysiology of AMAN is complex. In the early phase of the disease, the 
electrophysiology of patients with IgG antibodies to GM1, GM1b, GD1a and GalNAc - 
GD1a showed nerves with reduced distal CMAP amplitude, CB at common entrapment 
sites or with isolated absence of F-waves.75,76,77 Some of these patients on follow up 
showed progression to axonal degeneration typical of the AMAN pattern. Others had a 
rapid normalization of distal or proximal CMAP amplitudes without prolonged duration 
and/or restoration of F-waves without increased latency. In patients categorized as AMAN 
some nerves showed prolonged DMLs’. However, the DML increase was milder than in 
AIDP nerves in these patients and it rapidly resolved or persisted unchanged in sequential 
recordings. On the contrary, in AIDP in serial studies there is a progressive increase in 
DML usually.62, 73  
All the previously mentioned findings indicated that, the distinction between AMAN and 
AIDP is difficult or even impossible in the early phase of the disease, and that sequential 
electrophysiologic recordings are necessary for identification of GBS subtypes. Thus these 
studies suggested that the AMAN subtype was characterized not only by axonal 
degeneration but also by a reversible conduction failure; which is possibly mediated by 
antiganglioside antibodies.64, 75 
Acute motor conduction block neuropathy - 
 Capasso et al in 2003, reported about two interesting patients who developed acute onset 
of symmetric weakness without any associated sensory symptoms.78 There was history of 
antecedent diarrhoea in both patients (C. jejuni was isolated from one of them) and they 
carried high titres of IgG antibodies to GM1 and GD1a. Electrophysiological studies had 
shown distal CMAP amplitudes to be reduced, and also early partial motor CB in 
intermediate nerve segments (in ulnar nerves in the above - below elbow segment) with 
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normal sensory conductions even across the sites of motor CB and normal somato-sensory 
evoked potentials’. The muscle weakness improved and the distal CMAP amplitudes 
normalized and CB resolved in 2–5 weeks, without development of excessive temporal 
dispersion of either distal or proximal CMAPs’. There was a slowing of the motor nerve 
CV in the across elbow segment of the ulnar nerves’, in the range usually considered to be 
in the demyelinating range. This slowing was present from the very first recording, when 
CB was at maximum. Sequentially, the CV increased with the decrease of CB and returned 
to normal range when CB had disappeared without the development of excessive temporal 
dispersion of proximal CMAP. The above findings indicate that conduction slowing at CB 
sites, like the increased DML described in some AMAN nerves, are due to neither 
demyelination nor remyelination.  
It  may be explained  by preferential block of large diameter fastest conducting fibers, or 
altered resting membrane potential and sodium channel inactivation with delay of the 
action potential rising time. There are similar reports of five other patients. There was 
serological evidence of C. jejuni infection in four out of the five patients and another had 
diarrhoea.79, 80,81,82,83 Three patients had anti-GM1 and one anti-GM1b IgG antibodies, four 
patients recovered after IV Immunoglobulin or plasmapheresis in a few weeks. However, 
one patient worsened and progressed on to axonal degeneration. 
The above subgroup of patients were considered to represent a rare GBS subtype named 
‘acute motor CB neuropathy’ (AMCBN).78 Both AMCBN and AMAN have in common C. 
jejuni enteritis and antiganglioside IgG antibodies are associated with both groups. Also 
these AMCBN patients had the ‘reversible conduction failure pattern’ described in some 
AMAN patients in most of the tested nerves.75 Hence, it was hypothesized that AMCBN 
represents an ‘arrested AMAN’. Pathologically in these patients the anti-ganglioside 
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antibodies are thought to bind to the nodal axolemma and induce physiologic CB not 
progressing to axonal degeneration in any nerves.77 
It has been noted that even in AMAN patients with axonal degeneration, the recovery is 
more rapid and greater in grade than expected or when compared with other axonal 
neuropathies.84 Studies  indicates that, in AMAN patients, axonal  damage develops 
predominantly in the motor nerve terminal and only occasionally more proximal, 
providing the possibility for a good recovery as also shown by the time course of 
electrophysiological regeneration.  
Thus the term AMAN should no longer convey the meaning of “axonal degeneration” 
exclusively considering the dynamic process in AMAN pathogenesis. It is also debatable 
whether AMCBN or AMAN with reversible conduction failure should be recompiled in 
AMAN subtype or kept distinct.85 Therefore, the individuation of this form by proper 
interpretation of sequential electrophysiological findings is crucial to characterize GBS 
subtypes and establish prognosis. 
Acute motor and sensory axonal neuropathy - 
 A total of eight patients with an acute motor and sensory neuropathy (AMSAN) were 
described by Feasby and colleagues, 86 who met the clinical criteria for GBS, but in whom 
almost all motor and sensory nerves become in-excitable 4 to 10 days after onset of 
symptoms. Electromyography in these patients revealed extensive denervation.87 Most of 
the patients required mechanical ventilation and the outcome was poor. Autopsies and 
nerve biopsies in these patients showed axonal degeneration without evidence of 
demyelination or inflammation. AMSAN has been seldom reported, representing 1% of 
GBS in Japan88, 6% in India 57 and 15% in Israel 58. Anti-GM1, -GM1b and - GD1a IgG 
antibodies were present in two patients and one of the patients had serologic evidence of 
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C. jejuni infection.89 Similar to AMAN, the pathology in AMSAN is consistent with an 
antibody-mediated pathogenesis with the difference being that here the dorsal as well as 
the ventral roots are affected. 87 AMSAN can be considered to be the severe end of axonal 
GBS since AMAN and AMSAN share a common immunological profile and 
immunopathology. 
Electrophysiological criteria for GBS subtypes -  
Electrophysiology plays a critical role in the diagnosis of GBS and categorization into the 
various subtypes. However, even for the AIDP subtype, there is no consensus as yet over 
which of the published criteria offers the greatest diagnostic yield. Comparing the 
sensitivity of six criteria, two studies done showed that the number of patients that could 
be categorized as AIDP varied from 21 to 72%. 90, 91 The criteria proposed by Albers and 
colleagues 69 reached the highest sensitivity (64-72%). 90, 91 Ho and colleagues in 1995, 
modified the Albers criteria to differentiate AIDP from AMAN in the Chinese GBS 
population.61 ‘ Unequivocal temporal dispersion’ but not CB was enclosed among the 
parameters to assess demyelination in Ho’s criteria. However, how much temporal 
dispersion should be considered ‘unequivocal’ was not defined. AMAN was diagnosed by 
the absence of demyelinating features and the decrease of distal CMAP amplitude to less 
than 80% of lower limit of normal.61  
According to these criteria, 65% of GBS patients examined within the first 2 weeks of 
diseases had AMAN, 24% had AIDP and 11% were unclassified. Hadden and colleagues14 
substituted unequivocal temporal dispersion with CB in a revised version of Ho’s criteria. 
As it is known that motor nerves with very low CMAP amplitude due to axonal 
degeneration may have prolonged DML and F-wave latency or reduced CV, the presence 
of any single nerve with distal CMAP amplitudes less than 10% of the lower limit of 
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normal and ‘demyelinating features’ was not allowed to change the electrophysiological 
classification from primary axonal to demyelinating. The results of two 
electrophysiological tests performed approximately 4 weeks apart in 369 GBS patients 
from 11 Western countries, were examined. At the first test, 69% of patients met the 
criteria for AIDP and 3% the criteria for AMAN. At the second test, although the final 
proportion of AIDP (66%) and   AMAN (4%) were similar, many individuals changed 
classification.14 
Hadden’s criteria enclosed CB in the definition of primary demyelination. However, CB, 
promptly recovering without temporal dispersion and other characteristics of 
remyelination, has been described in AMCBN and AMAN patients with ‘reversible  
conduction failure’.75,76,78  
In a GBS series from Japan analysed utilizing Ho’s criteria, some of the patients carrying 
anti ganglioside antibodies recorded sequential change in electrophysiology  from AIDP to 
AMAN or recovered from the AMAN pattern or from the ‘isolated F-wave absence’ 
pattern to normal. 59, 64 
Difficulty in distinguishing AMAN and AMCBN from AIDP arises from the fact that 
some of the electrophysiological features attributed to segmental demyelination can occur 
with variable degrees of nodal injury in axonal GBS. Also, some patients with AIDP may 
develop such profound secondary axonal involvement that demyelinating features may no 
longer be evident. 
 In an Indian study, by Kalita et al 57(cross sectional study) with 51 GBS patients, of whom 
25 patients had presented in the first week of the onset of symptoms, 16 in the second 
week and 10 patients who presented in the third week of illness were analysed, the 
sensitivity of the various criteria were analysed and the results were as follows:- 
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Criteria 1st  week  
(25 patients) 
     2nd week 
 (16 patients) 
      3rd week 
 (10 patients) 
Alber’s       88 %        87.5 %       90 % 
Alber’s & Kelly       48 %       43.8 %       60 % 
Cornblath       32 %       37.5 %      60 % 
Ho’s       88 %       81.3 %      90 % 
 
In a recent study by Uncini et al 4, it was found that out of 55 patients who underwent at 
least two serial electrophysiological studies with a mean duration of 28 days between the 
tests , in the first test electrodiagnosis using the Ho and Hadden criteria were identical : 65-
67 % were classifiable as AIDP,18 % were classifiable as Axonal GBS  and 14- 16 % were 
equivocal .At follow up it was found that there was a change in classification in 24 % of 
patients : AIDP decreased to 58%, axonal GBS increased to 38 % and equivocal patients 
decreased to 4%. It was noticed that the majority of shifts were from AIDP and equivocal 
groups to axonal GBS. Again the main reason was that serial recordings were able to 
recognise the reversible conduction failure and length dependent CMAP amplitude 
reduction as expression of axonal pathology. 
 Thus, it is important to note that serial electrophysiological studies are helpful and should 
be mandatory for the identification of GBS subtypes and to elucidate the pathophysiologic 
mechanisms of muscle weakness among demyelination, axonal degeneration and 
physiologic CB. In order to determine if physiologic conduction failure or demyelination 
underlie CB, electrophysiological recordings should be repeated through some weeks in 
order to document increased CMAP duration due to excessive temporal dispersion, which 
is the electrophysiological correlate of remyelination. 
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                         AIMS AND OBJECTIVES 
 
The primary aims and objectives of the study were:-  
• To evaluate the utility of multiple segment stimulation- including proximal  
Conduction - in nerve conduction studies of patients with Guillain-Barre Syndrome. 
• To determine whether multiple segment stimulation of nerves helps in the early 
 detection of conduction blocks in patients who present in the first week of illness. 
• To do serial nerve conductions studies and investigate what changes are seen  
and its influence on the initial classification as per established published criteria. 
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MATERIALS AND METHODS 
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DATA COLLECTION  
Setting:  
Patients admitted under the Department of Neurology at Christian Medical College, 
Vellore and diagnosed to have Guillain- Barre Syndrome were included in the study. The 
study protocol was approved by the Institutional Review Board (IRB) of the institution. 
Period of recruitment:  
14 months (January 2010 to February 2011) 
Participants:  
Inclusion Criteria  
 All newly diagnosed, treatment naïve patients above 18 years of age who 
presented within first week of illness and satisfying the clinical diagnostic criteria for 
typical Guillain-Barre syndrome who consented for the study were included for clinical 
evaluation and serial nerve conduction recordings. 
Clinical diagnostic criteria for typical Guillain- Barre Syndrome: - 
Features required for diagnosis:- 
     Progressive weakness in both arms and both legs  
     Areflexia  
Features strongly supporting diagnosis:- 
     Progression of symptoms over days to four weeks  
     Relative symmetry of symptoms  
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     Mild sensory symptoms or signs  
     Cranial nerve involvement especially bilateral weakness of facial muscles  
     Recovery beginning 2- 4 weeks after progression ceases  
    Autonomic dysfunction 
    Absence of fever at onset  
    High concentration of protein in cerebrospinal fluid with fewer than 10 cells 
Exclusion criteria 
1. Diagnosis of botulism, myasthenia, poliomyelitis or toxic neuropathy 
2. Abnormal porphyrin metabolism 
3. Recent diphtheria  
4. Purely sensory syndrome without weakness   
 
Electrophysiological criteria for GB syndrome- AIDP variant
Albers et 
al (1 in 2 
nerves)
Albers& 
Kelly (3 
or more)
Ho et al 
(1 in 2 
nerves)
Dutch GBS 
study group (1 
in 2 nerves)
Cornblath et al 
(3 or more)
Italian GBS 
study group (
in 1 nerve)
Conduction 
velocity 
reduction
<95%
<85%
<90%
<80%
(2 nerves)
<90%
<85%
<70% <80% (A>80%)
<70% (A<80%) 
(2 nerves)
<80%
<70%
(2 nerves)
Distal 
latency 
prolongation
>110%
>120 %
>115%
>125 %
(2 nerves)
>110%
>120 %
>150% >125%
>150 %
(2 nerves)
>125%
>150 %
(2 nerves)
Temporal dispersion 
(Prox-distal duration 
increase )
>30% > 30%
(1nerve)
> 30% Distal-prox 
duration
>150%, distal 
duration>300%
>15%, with 
>20% 
amplitude 
decrease 
(1nerve)
> 30%
(1nerve)
Conduction block        
( Prox:Dist amplitude 
ratio)
<0.7 <0.7 
(1nerve)
Amplitude 
decrease>ULN
<15%, with 
>20% 
amplitude 
decrease
<0.7 (1nerve)
F-wave latency 
prolongation
>120% >125%
(1nerve)
>120% >150% >120%
>150 %
(2 nerves)
>120%
>150 % 
(2nerves)
A > 50%
A < 50%
A : Normal
A < Normal
      ------------------------------------------------------------------------------------------------------------------- 
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Abbreviations:- 
Amp - CMAP amplitude (lower limits of normal); dist – distal  
dur    - CMAP duration;   NP – negative peak;   prox – proximal. 
AIDP – Hadden et al - 
At least one of the following in each of at least two nerves or at least two of the following    
in one nerve if all others in excitable and d CMAP ≥ 10 % LLN 
 Motor conduction velocity <  90 %  LLN ( < 85 % if d CMAP < 50 % LLN) 
 Distal motor latency           > 110 % ULN ( > 120 % if dCMAP < 100 % LLN) 
 pCMAP/ d CMAP ratio < 0.5 and d CMAP   ≥  20 % LLN  
 F response latency  >  120 % 
Of the above seven criteria, we used the following five criteria for the analysis of the 
electrophysiology data in our study:- Set 1 (Alber’s), Set 2 (Alber’s and Kelly), Set 3 
(Cornblath) , Set 4 ( Ho’s criteria),  Set 5 ( Hadden’s criteria).    
 AMAN CRITERIA  :- 
Ho et al . (1995) 
 No evidence of demyelination as described in AIDP 
 dCMAP <80 % LLN in atleast two nerves 
           Hadden et al .(1998) 
 None of the features of demyelination in any nerve as defined in AIDP except 
one demyelinating feature allowed in one nerve if dCMAP < 10 % LLN 
 dCMAP < 80 % LLN in at least two nerves 
      Sensory action potential amplitudes normal 
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 AMSAN CRITERIA:- 
Feasby et al (1993); Rees et al (1995) 
No evidence of demyelination  
 d- CMAP  < 80 % LLN in at least two nerves or in excitable nerves  
 Sensory nerve action potential amplitude <50 % LLN 
Methods:  
All patients with Guillain- Barre syndrome, who fulfil the inclusion criteria, were recruited 
in the study after informed consent. Demographic information, etiological factors and 
laboratory data were collected as per study protocol (Appendix 1). The study subjects then 
underwent a nerve conduction study at temperature greater than 32 degree Celsius using a 
standard ENMG machine (Nicolet Viking Quest).Stimulus duration was 0.2 ms in all 
examinations, with the intensity ranging from 20 to 100 mA for obtaining supramaximal 
stimulation. 
a) Motor nerve conduction parameters :- compound muscle action potential- amplitude ( 
peak to peak), latency, duration, velocity- of two motor nerves each in bilateral upper 
(median and ulnar nerves ) and lower limbs (peroneal and tibial nerves).  
 -  Multiple segment stimulation of  – bilateral median and ulnar in the upper limb 
including Erb’s point stimulation were done as part of nerve conduction study for patients 
admitted with suspected Guillain Barre syndrome at the time of admission  and once 
weekly thereafter till the power improved by one Hughes grade or till discharge. 
Median nerve stimulation at the following sites and CMAP recording done at the abductor 
pollicis brevis muscle:-  
1) Wrist                                                                     2)   Elbow  
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3) Axilla                                                                    4)   Erb’s point      
Ulnar nerve stimulation at the following sites and CMAP recording was done at the 
abductor digiti minimi muscle:- 
 1) Wrist                                                                    2) Below elbow 
 3) Above elbow                                                       4) Erb’s point  
Peroneal nerve stimulation at the ankle and fibular head and CMAP recording was done at 
the extensor digitorum brevis muscle. 
Tibial nerve stimulation at the ankle and popliteal fossa and CMAP recording was done at 
the abductor hallucis muscle. 
The CMAP parameters determined to evaluate conduction abnormalities in the forearm 
segment and across the elbow segment were:- 
Amplitude decrement (%) - calculated as (distal CMAP amplitude – proximal CMAP 
amplitude) × 100 / (distal CMAP amplitude); 
Temporal dispersion (%) - calculated as (proximal CMAP duration / distal CMAP 
duration) × 100.  
Based on the consensus criteria of the American Association of Electrodiagnostic 
Medicine, definite partial conduction block was defined as an amplitude decrement of 
more than 50% with <30% temporal dispersion. Probable partial conduction block was 
defined as an amplitude decrement of 40–49% with <30% temporal dispersion. The above 
criteria were applied only to a nerve in which the distal CMAP amplitude was 20% or 
more of the lower limit of normal. 
 
Page | 32  
 
ROOT STIMULATION – TECHNIQUE - Patients who gave consent underwent a 
monopolar electrical stimulation across the C8 root to abductor digiti minimi, to assess for 
any conduction block - Electrical stimulation was done using a 75 mm mono polar needle 
with a 3mm bare tip placed onto the C7 lamina with a surface anodal plate lateral to it. 
Supramaximal stimuli were given and evoked response was measured for latency, area and 
amplitude.  
The following parameters were also studied:-  
a)  Sensory nerve conduction – amplitude and conduction velocity   
(Bilateral median and ulnar in the upper limbs and bilateral superficial peroneal and sural 
nerves in the lower limbs).  
b) F- wave latencies in the upper and lower limbs nerves 
     -  Upper limbs  -   bilateral median and ulnar nerves. 
     -  Lower limbs -   bilateral peroneal and tibial nerves. 
 c) H reflex  -  bilateral -  amplitude and latency - evaluates the S1 root 
d) Phrenic nerve stimulation – bilateral - latency and amplitude -  
Technique - Electrical stimuli at 100 - 200 msec are applied at the posterior border of the 
sternomastoid, cathode being inferior to anode about 3 cm above the clavicle. The active 
recording electrode is placed at the xiphisternum and reference at the costal margin 16 cm 
away from the active electrode. Neck should be neutral or slightly extended.  
e) Femoral nerve stimulation – was stimulated above and below the inguinal ligament just 
lateral to the femoral artery. Surface recording electrodes are placed over the belly of the 
vastus medialis and the reference electrode just proximal to the patella. 
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 f) Blink reflex 
 g) Facial nerve conduction – Bilateral  
 h) Sympathetic Skin Response  - in the upper and lower limbs 
      -  which assesses the function of the small diameter fibres.   
 i) Needle EMG study: findings - insertional activity, motor unit potential - amplitude,   
duration, interference  
               Lower limbs  -  Tibialis Anterior,  Vastus lateralis 
               Upper limbs  -   Abductor pollicis Brevis, Biceps 
For DML, CV, F - wave latency, CMAP and SNAP amplitude we defined the upper and 
lower limits of normal as the mean plus / minus 2 SD of the control values of our 
laboratory which gives a 95% CI. 
Control values at our electrophysiological laboratory:-  
Nerve  
 
Dist latency 
(msec) 
Amp(mV, 
microV) 
Conduction 
velocity(m/s) 
F wave (msec) 
Median motor 3.12 ± 0.62 12.0 ± 5.0 54.9 ±10.9 26.6 ±3.5 
Median sensory 2.27 ± 0.44 25.6 ±10.0 57.4 ± 11.9  
Ulnar motor 2.17 ± 0.55 9.0   ± 3.0 59.4 ±10.9 26.6  ± 3.5 
Ulnar sensory  1.8   ± 0.62 20.4 ± 9.6 56.4 ± 10.7  
Peroneal  3.56 ± 1.22 8.0 ± 2.62 46.5 ± 7.78 47.8 ± 5.9 
Sural sensory 2.36 ±0.62 8.0 ±2.62 48.2 ±  9.8  
 
Since we did not have a control value for the tibial nerve conduction parameters and 
proximal stimulation was technically difficult it was not included in the final analysis. In 
serial recordings of the same patients, distal CMAP amplitude was considered significantly 
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increased when higher than 50 % of the values found at the first study. Electrophysiology 
was performed in all patients at least twice and five patients had at least three conductions 
done. 
CLINICAL GRADING: - HUGHES FUNCTIONAL GRADING-  
Hughe’s grade was assessed for all patients at admission and at discharge. Any change 
during the course of hospital stay was also noted. 
HUGHES GRADE Clinical status 
GRADE    0 Normal 
GRADE    1    Minimal signs and symptoms, able to run 
GRADE    2    Ambulates independently 
GRADE    3    Able to walk 5 metres with aid 
GRADE    4 Bed bound 
GRADE    5 Requires mechanical ventilation 
GRADE    6 Dead 
 
 Other variables:- CSF – TC, DC, Sugar, Protein  
                             Blood – HIV, serum Potassium   
                             Urine - porphobilinogen  
STATISTICAL ANALYSIS:- 
All the data was entered into SPSS (version 15 for windows) .The mean distal motor 
latency, CMAP amplitudes and F- wave latencies (with standard deviation) were 
calculated for the first and second nerve conduction study. Chi- square test was done for 
testing the significance of the involvement of the upper limb median SNAP’s compared to 
that of the sural SNAP’s. Probability value (p value) less than 0.05 was considered 
statistically significant.    
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RESULTS 
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Data was collected from a total of ten patients who presented within the first week of onset 
of symptoms and admitted with a clinical diagnosis of Guillain -Barre syndrome (fulfilling 
the inclusion and exclusion criteria) during the study period. All the ten patients had at 
least two electrophysiology tests with a minimum gap of seven days while five patients 
had atleast three conductions (one patient in this group had six conductions). The third 
conduction was done approximately twenty days after the onset of the illness. The mean 
time from the onset of neurological symptoms to the first electrophysiological study was 
4.1 days. 
 The baseline characteristics of the study population are as follows:- 
1) Age distribution:- 
 
AGE
41 - 60 years21 - 40 years18 -20 years
50
40
30
20
10
0
 
Of the ten patients in the study group, four patients were in the age group of 18 to 20 years 
and another four were in the age group of 41 to 60 years. There was no patient with age 
less than 18 years or more than 60 years in the study group. 
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2) Sex distribution:-  
 
     
70.0%
30.0%
MALE
FEMALE
 
 
3)  Antecedent events:- 
 
Events     No of patients  
Diarrhoea            2 
Upper Respiratory Infection            1 
Fever with arthralgia           2 
Vaccination           0 
No events           5 
 
 
 
4) Duration from onset to nadir:- 
 
 No of patients 
24 -  36 hours          1 
36 -  72 hours          1 
72 hrs – 7 days          6 
8days – 14 days          1 
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5) Cranial nerve Involvement:- 
 
Cranial Nerve Involvement        No of patients  
Extra-ocular Involvement                0 
Bifacial weakness               7 
Bulbar weakness               4 
 
6) Hughes Grade at admission and discharge: - The following bar diagram depicts the 
Hughes grade at admission and discharge in the ten patients who were treated with 
plasmapheresis.  
Case Number
10987654321
V
a
lu
e
6.0
5.0
4.0
3.0
2.0
1.0
Hughes grade Adm
Hughes grade Disch
  
Patient number 5 - at admission had a Hughes grade 4; however on the fourth day he 
worsened and was mechanically ventilated (grade 5). He was gradually weaned off after 
110 days of ventilation and discharged for rehabilitation (grade 4). 
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7) Deep tendon reflexes: - Nine out of ten patients had absent deep tendon reflexes. The 
remaining one had her reflexes just elicitable during the course of her illness though her 
conductions were classified as acute demyelinating polyradiculoneuropathy. 
 
8) Sensory Symptoms: -  
 
Sensory Complaints        Yes       No 
Painful Paraesthesias         6       4 
Sensory loss        1       9 
 
Of the ten patients, one patient complained of whole body paraesthesias with involvement 
of the trunk and face. 
9) Hughes grade improvement after treatment at follow up (1 month):- 
    
 Number of patients Percentage (%) 
Improvement by at least 
one grade  
       9          90 
 No improvement        1          10 
Total        10        100 
 
10)  Urinary Bladder Involvement:- 
 
Of the ten patients in the study only one patient had bladder  complaints in the form of   
urinary retention on the fourth day of illness (first day of admission ) necessitating  
catheterisation and it persisted till ten days .(Trial of catheter removal was done but had to 
be reinserted due to retention ). A MRI screening of the whole spine was done for this 
patient to rule out any spinal cord pathology which was normal. She also had other 
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features of significant autonomic involvement- like abnormal blood pressure responses 
during plasmapheresis.   
LAB INVESTIGATIONS:- 
All the ten patients were evaluated to rule out underlying HIV infection - (HIV Elisa  
negative in all patients) and the serum potassium and CPK assay were within normal 
limits. The urine porphobilinogen assay was also negative in all the patients. 
11)  CSF abnormality:- 
 
 Normal  Elevated Total patients 
Total cell count  10 - 10 
CSF Protein  6 4 10 
 
The CSF protein was elevated (> 45 mg /dl) in only four patients out of ten which is 
expected as the CSF study was done in the first week of illness. Of these, only two patients 
had CSF protein > 60 mg /dl.   
12) Treatment: - 
All the ten patients were treated with plasmapheresis (mean volume removed – 5 litres). Of 
this, one patient could not tolerate plasmapheresis after 3.3 litres - as she developed severe 
hypotension and bradycardia (associated with severe autonomic dysfunction). Hence she 
was started on treatment with IV Immunoglobulin (2gms/ Kg). 
13)  Average duration of Hospital stay: -   
The average duration of hospital stay was around twenty days for nine patients while one 
patient had a prolonged stay of around five months requiring long term mechanical 
ventilation for 110 days. 
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 ELECTROPHYSIOLOGICAL PARAMETERS 
  We analysed the results of the multiple segment stimulation of the median and ulnar 
nerves in the upper limbs to assess for the presence of conduction blocks across the 
different segments and also the results of the proximal conductions (blink reflex, facial 
nerve, phrenic nerve, H -reflex and femoral and saphenous conductions) in the first week 
to assess for any abnormality indicative of proximal involvement in the early stages of 
Guillain Barre syndrome.   
14)  Motor nerve conduction studies: - 
Total number of nerves studied:- 
Nerves studied  First study (n  = 10) Second study (n  =  10)  Third study (n   =   5) 
Median          20          20          10 
Ulnar          20          20          10 
Peroneal          20          20          10 
Total         60          60          30 
 
n = number of patients studied 
The various published criteria ( Alber’s,  Alber’s and Kelly,  Cornblath, Ho et al and 
Hadden criteria  - for AIDP and the Ho et al Criteria - for AMAN ) were used to analyse 
the sequential nerve conduction studies. Then we analysed the number of patients who 
satisfied the criteria in the first week and in the subsequent study and assessed whether 
there was a change in the classification in the subsequent study. 
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15) Results of the first nerve conduction study (motor nerves) in patients with Guillain 
Barre Syndrome: - 
Nerve  Distal Latency 
(msec) 
CMAP amplitude 
( mV) 
CV ( m/s) F wave latency 
(ms) 
Median (n=20)     
  In excitable   0       (   0 %)     0       ( 0 %)     0    3     (15 %) 
  Abnormal   8       ( 40 %)     7       (35 %)     1     (  5  %)    8     (40 %) 
  Normal  12      ( 60 %)   13      ( 65 %)   19     (95  %)    9     (45 %) 
  Mean  (SD) 3.87 (1.23)  8.94 ( 5.29)    56.2 (6.60)   33.02 (11.22) 
Ulnar ( n =20)                                   
  In excitable   0        (  0  %)       0       (  0 %)      0    7     (35 %) 
  Abnormal  12       ( 60 %)     9       (45 %)      3    ( 15 %)    7     (35 %) 
  Normal    8        (40  %)   11       (55 %)    17    ( 85 %)    6     (30 %) 
  Mean ( SD) 3.03 (0.53) 6.34 ( 4.76) 63.20(6.69)    32.03 
Peroneal (n=20)     
  In excitable   0        (  0  %)     1       (  5 %)     0    3     (15 %) 
  Abnormal    9        ( 45 %)   10       (50 %)     2      (10%)    8     (40 %) 
  Normal  11       (55  %)       9      ( 45 %)   18      (90%)    9     (45 %) 
  Mean ( SD) 5.11 (1.91) 4.63 (3.08) 47.00 ( 7.13) 56.83 (22.05) 
 
       n= number of nerves studied. 
The most common abnormalities detected in the first nerve conduction study were the 
prolonged F- wave latency (35- 40 %) / in-excitable F- waves (15 -35 %) and prolonged 
distal motor latency (range from 40 - 60 %) in both the upper and lower limb nerves. 
Around 40 to 50 % of nerves showed a decrease in the CMAP amplitude. The conduction 
velocities showed abnormalities only in 10- 15 % of the nerves. Majority of the 
abnormalities were picked up in the ulnar nerves.  
Page | 43  
 
16) Results of the second nerve conduction study (motor nerves) in patients with 
Guillain - Barre Syndrome – 
Nerve  Distal Latency 
(msec) 
CMAP amplitude 
( mV) 
CV ( m/s) F wave latency 
(ms) 
Median (n=20)     
  In excitable  4         (20 %)   4        (20 %)   4      (20%)    4    (20 %) 
  Abnormal  9         (45 %)   8        (40%)   4      (20 %)          9    (45 %) 
  Normal  9         (45 %)   8        (40 %)  12     (60 %)    7    (35 %) 
  Mean  (SD)    5.18 (2.14)    6.78 (4.75) 40.85 (22.43) 34.87 (13.15) 
Ulnar  ( n =20)     
  In excitable  4         (20 %)   4         (20 %)   4      (20 %)    8    (40 %) 
  Abnormal 10        (50 %)   9        (45 %)   6      (30 %)    7    (35 %)  
  Normal    6        (30 %)   7         (35 %)  10     (50 %)    5    (25 %) 
  Mean ( SD)   4. 17 (1.94)  4.90 (3.41) 42.75 (23.60) 34.71( 16.84) 
Peroneal (n=20)     
  In excitable   4        (20 %)   4        (20%)   4       (20 %)    6     (30 %) 
  Abnormal    9        (45 %)  10       (50 %)   6       (30 %)    7     (35 %) 
  Normal   7        (35 %)    6       (30%)  10      (50 %)    7    (35 %) 
  Mean ( SD)   6.72 (2.41) 2.78 ( 2.30) 32.10 (17.98)  59.86 (26.08)  
  n =  number of nerves studied. 
At the time of the second conduction study, in two patients all the motor nerves became in 
excitable. There was an increase in the mean distal motor latency in the rest of the nerves 
and more number of nerves showed a prolongation of the distal motor latency and F wave 
latencies compared to the first conduction. (This is as expected during the course of  
AIDP).There was a corresponding decrease in the mean compound muscle action potential 
amplitude in all the three motor nerves studied compared to that in the  first conduction.  
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17)  Results of sensory nerve conduction abnormalities (amplitude) in the first and 
second conductions: - 
Nerve ( SNAP) Ist conduction (n = 20 ) 2 nd conduction( n= 20) 
Median sensory    
   In excitable         0           0 
   Normal         16        (80 %)          14          (70 %) 
  Abnormal          4         (20 %)           6           (30 %) 
  Mean (SD)       28.80 ( 12.23)          29.55 ( 21.93) 
Ulnar sensory    
   In excitable        0             0 
   Normal        17        (85 %)         15          (75 %) 
   Abnormal         3         (15 %)          5           (25 %) 
   Mean (SD)      20.85 (  7.20)          22.15 ( 11.26) 
Sural sensory   
   In excitable       0           0 
   Normal       20        (100%)          19        (95 %) 
   Abnormal       0          (0   %)          1          (05 %) 
   Mean ( SD)      25.05 (12.84)          20.90 ( 8.91) 
 
n= number of nerves studied 
There was greater involvement of the upper limb sensory conductions (more number of 
Median and Ulnar sensory action potential amplitudes were in the below normal range) 
compared to the lower limb sensory conductions (sural sensory action potential amplitude)  
in both the first and second study with a significant p- value (median to sural 1st 
conduction p = 0.037, 2 nd conduction p = 0.021) . 
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18)   Results of third nerve conduction study in patients with Guillain Barre Syndrome. 
(number of patients studied is five)    
Nerve  Distal Latency 
(msec) 
CMAP amplitude 
( mV) 
CV ( m/s) F wave latency 
(ms) 
Median (n=10)     
  In excitable       2        2         2         4 
  Normal       2        2         3                         1 
  Abnormal       6        4         3         5 
  Mean  (SD)    5.78 (1.87)      4.38 (3.65)    32.85 
(21.34) 
34.27 (14.25) 
Ulnar  ( n =10)     
  In excitable      2        2        2         5 
  Normal      0        3        2         1      
  Abnormal       6        5            4         4 
  Mean ( SD)   4.62 (1.10)     2.56 (2.41) 40.64 (22.16) 35.73( 16.84) 
Peroneal (n=10)     
  In excitable       2        2         2        5 
  Normal        0        2        3        1 
  Abnormal       6        4        5        4 
  Mean ( SD)   6.82 (1.32) 2.46  (1.26) 26.10 (15.73)  59.74 (24.08)  
 
Only five patients were followed up with a third nerve conduction study. Of these, two 
patients had completely in excitable motor nerves with sensory nerves being elicitable. 
There was a prolongation of the mean distal motor latency and reduced CMAP amplitude 
in the rest of the patients compared to the second study. 
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19)  Analysis of conduction block across multiple segments of Median nerve in the first 
and second serial nerve conduction tests: -   
Conduction block  1st  study ( n=20) 2nd  study (n=20) 
Segments studied Definite           Probable   Definite Probable 
       Wrist   /  Elbow 2  (10%) 4     (20 %) 3 ( 15 %) 3   (15 %) 
       Elbow / Axilla 0 1     (  5 %) 0 0 
 
Though multiple segment stimulation was done including the axilla to Erb’s point 
stimulation the proximal stimulation values were not used in the final analysis of 
conduction block due to the possibility of technical fallacies with Erb’s point stimulation – 
especially in an intensive care setting. At the time of second study in two patients all the 
motor nerves became in-excitable while the sensory nerves were excitable.  Hence there is 
an apparent decrease in the number of motor nerves showing conduction block in the 
second study.  
20) Analysis of conduction block across multiple segments of the Ulnar nerve in the first 
and second serial nerve conduction tests. 
Conduction block     1st  study (n=20)         2nd study (n=20) 
 Segments studied–  Definite Probable Definite Probable 
    Wrist / Below elbow   4  ( 20 %) 1    (5%) 3  (15 %) 0 
    Below / Above elbow   8  ( 40 %) 0 2  (10 %) 3    (15 %) 
 
21) Analysis of conduction block in the peroneal nerve in the first and second 
conduction:-  
      1st   study ( n=20 )       2nd   study  (n =20) 
Definite Probable Definite  Probable 
Conduction block   6( 30%) 3      (15%) 10  (50 %) 1      (5 %) 
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     22) Patterns of H - reflex abnormality in the study group:- 
     1st study ( n =20)      2nd study ( n=20) 
In- excitable         8         (40 %)       8        ( 40 %) 
Reduced amplitude       12        (60 %)      12        ( 60 %) 
Prolonged latency and 
Reduced amplitude  
       2         (10 %)        7       (  35 %) 
  
(Reference value - prolonged latency - > 35 ms. Reduced amplitude reference value < 
3.7 mv). 
H-reflex
Reduced Amplitude
Prolonged latency
inexcitable
100
90
80
70
60
50
40
30
20
10
0
1st conduction
2 nd conduction
 
The amplitude of the H - reflex response was grossly reduced in all the ten patients 
bilaterally in both studies and there was no response to stimulation in eight of the studied 
responses. 
23) Analysis of Phrenic nerve conductions in the first and second study:-  
The phrenic nerve latencies and amplitude were studied in the ten patients. The upper limit 
of normal latency was taken as 8.4 ms and the lower limit of normal amplitude was taken 
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as 300 microvolt. Though a total of five patients showed conduction abnormalities in the 
unilateral or bilateral latency or amplitude variables, of these only two patients required 
ventilatory support.  
 Phrenic nerve conduction abnormalities 1st study (10 pts) 2nd study(10pts) 
Prolonged latency     -  U/L      2   1 
Prolonged latency     -  B/ L      2   2 
Reduced amplitude  -  U/L      1   0 
Reduced amplitude  -   B/L       0   2 
Prolonged latency & reduced amplitude –B/L    
     0   0 
No response             -   B/L      1   1 
 
The first patient was intubated and ventilated within one hour of admission. He had no 
response to phrenic stimulation bilaterally in the first study. He was weaned off the 
ventilator after nine days and in him the phrenics became excitable with reduced amplitude 
and prolonged latency at the time of the second conduction(9th day).In the second patient 
the phrenic nerve stimulation showed only prolonged latency bilaterally in the first study. 
He was intubated on the fourth day after admission following breathing difficulty and 
arterial blood gas analysis showed carbon dioxide retention. Phrenic nerves became totally 
in excitable in the second conduction and he was on ventilatory support for 110 days. The 
motor nerves as well as the phrenic nerves were totally in-excitable during this period. The 
phrenic nerves became excitable (on one side on 100th day) and he was gradually weaned 
off the ventilator. 
24)   Blink reflex abnormality: - 
Of the ten patients in the first study only one (patient no- 3) had evidence of blink reflex 
abnormality in the form of prolonged ipsilateral and contralateral R 2 latency with bilateral 
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involvement. In the second conduction, two patients (patient 3 and 7) had evidence of 
bilateral blink reflex abnormality. (None had unilateral abnormality in either of the two 
studies). 
25) Femoral nerve conductions: - 
The femoral nerves were excitable in all the patients studied (only eight patients studied). 
The latencies were within normal limits but there was gross asymmetry between the 
amplitudes between the right and the left sides in four of these patients in the first 
conduction. Two patients had femoral nerve stimulation done only on one side due to the 
placement of the femoral catheter line for plasmapheresis. 
 In one of these patients the femoral nerve response showed significant increase in 
amplitude in the second study as the patient started improving in motor power while there 
was no improvement in the other parameters. In patient no: - 5 the femoral nerves which 
were excitable in the first conduction however became in- excitable in the second 
conduction (along with the other motor nerves). 
 26)    Root stimulation: - 
Cervical root stimulation (C8) and recording was done on the abductor digiti minimi 
muscle in one of these patients and it showed the presence of definite conduction block – 
decrease in the CMAP across the axilla to root segment. (print out added in the annexure)  
27)   Sympathetic skin response: - 
Of the ten patients in the study group, eight patients underwent sympathetic skin response 
testing as a part of autonomic function test evaluation. The Sympathetic skin response was 
absent in both the upper and lower limbs in five of the eight patients. 
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28) Summary of the proximal conduction abnormalities in the study group in the first 
and second conduction – 
Parameters 1st study 2nd study 
H – reflex abnormalities    100 %     60 % 
F – waves -  upper limbs Median      55 %     45 % 
Ulnar     70 %     55 % 
F –waves  - lower limbs - Peroneal     55 %     45 % 
Blink reflex     10 %     20 % 
Conduction 
blocks 
 
Median Wrist / elbow     30 %     30 % 
 Elbow / axilla       5 %       0 % 
Ulnar Wrist / below elb     25 %      15 % 
Across elbow     40 %     25 % 
Peroneal     45 %     50 % 
Femoral response( 8 pts studied)     50%       
Phrenic Nerve stimulation     50 %     50 % 
 
The most common abnormalities in the first conduction were H- reflex and F- wave 
parameters. (In the second conduction as two patients showed complete in-excitability of 
the motor nerves these abnormalities could not be commented upon in these patients.) The 
femoral nerve stimulation also showed significant abnormality (with asymmetrical 
amplitude) suggestive of proximal involvement. 
29)  Needle EMG: - Needle EMG of the APB and the Tibialis anterior was done in 
(patient No - 5 - who went on to require prolonged conduction) about two weeks into the 
illness (at the time of second conduction). The needle EMG showed moderate evidence of 
active denervation in the form of fibrillations and positive sharp waves. The corresponding 
nerve conduction test had showed that all the motor nerves were totally in-excitable. 
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30)  Classification of the serial electrophysiological studies by the application of the five 
electrophysiological criteria:- 
SET ( I ) Flow chart showing the Alber’s Criteria applied to the first and second 
conduction: 
Total study group 1
st NCV 2nd NCV
10 patients 
10 - AIDP
0 -
Unclassifiable
8 - AIDP
2 -
inexcitable
 
SET  (II) Flow chart showing the Alber’s and Kelly Criteria applied  to first and second 
conduction :- 
Total study group 1
st NCV 2nd NCV
10 patients 
3 - AIDP
7 -
Unclassifiable
2 - AIDP
1 -
Inexcitable
6 - AIDP
1- inexcitable
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 SET (III) Flow chart showing the Cornblath criteria applied to the first and second 
conduction :-
Total study group 1
st NCV 2nd NCV
10 patients 
3 - AIDP
7 -
Unclassifiable
2 - AIDP
1 -
Inexcitable-
3-
unclassifiable
3 - AIDP
1- Inexcitable
 
  SET (IV) Flow chart showing the Ho et al  criteria applied to the first and second  
conduction :-  
 
Total study group 1
st NCV 2nd NCV
10 patients 
9 - AIDP
1 -
Unclassifiable
7 - AIDP
2 -
Inexcitable
1 - AIDP
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SET (V)  Hadden’s  criteria applied to the first and second conduction :- 
Total study group 1
st NCV 2nd NCV
10 patients 
10 - AIDP
0 -
Unclassifiable
8 - AIDP
2 -
Inexcitable
 
(VI)  Sensitivity of the various criteria (in percentage) in the diagnosis of AIDP in the first, 
second and third conductions: - 
Criteria  
 
 
 1st conduction 
( n = 10 ) 
2nd conduction 
    (n = 10 ) 
3 rd conduction 
    ( n = 5) 
Alber’s criteria 
 
100 % 80 %   80 % 
Albers and Kelly  
 
  30 %    80 %   80 % 
Cornblath criteria 
 
  30 % 50 %   60 % 
Ho’s criteria  
 
  90 %  80 %   80 % 
Hadden’s criteria  
 
100 % 80 %   80 % 
 
Two patients who initially satisfied the Alber’s and Hadden’s criteria at the first 
conduction progressed to completely in-excitable motor nerves at the time of the second 
conduction. Otherwise the rest of the eight patients satisfied the various criteria for AIDP 
except Cornblath’s criteria in the second conduction. Only five patients were followed up 
in the third week conduction (of these one patient had in-excitable motor nerves. The 
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second patient with in excitable nerves was discharged at request).Analysis again showed 
high sensitivity with all the criteria except Cornblath’s criteria. 
Figure: - Comparison of the various criteria applied to the first and second conduction. 
(Third conduction not shown as only five patients were studied) 
 
GBS Diagnostic Criteria
HaddenHo'sCornblathAlb&KeAlbers
12
11
10
9
8
7
6
5
4
3
2
1
0
1stconduction
2ndconduction
 
One of the two patients with completely in-excitable motor nerves in the second 
conduction (with rapid progression to nadir with no significant response to treatment with 
plasmapheresis); also had evidence of active denervation in EMG in the second study and 
it was taken as being suggestive of an axonal pathology. (Acute motor axonal neuropathy- 
AMAN).In the other patient needle EMG was not done at the time of the second  
conduction and hence cannot be classified as AMAN with accuracy. In these patients the 
first conduction had shown evidence of conduction block and fulfilled the criteria for 
AIDP. However both patients had antecedent history of diarrhoea and both did not have 
significant facial nerve involvement. Both these patients had poor response to treatment. 
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Various studies have shown that the diagnostic yield of the different electrophysiological 
criteria may vary in the different subtypes of Guillain- Barre syndrome, whose prevalence 
varies in the different geographical areas of the world. The percentages of patients 
diagnosed with demyelinating and axonal Guillain- Barre syndrome has been found to 
vary substantially in different published series. This may be attributed to the following 
factors - genetic susceptibility, different triggering factors, electrophysiological criteria 
used and whether the electrodiagnosis was based on a single study or serial studies. 
Majority of the published studies are cross sectional studies. 
In this study, we have done serial conductions in ten patients who presented within the first 
week of onset of symptoms – either till they improved by one grade or till four weeks. 
Thus, in the group studied all ten patients had at least two conductions with a minimal  
interval between the studies of seven days and five patients had at least three conductions 
with the mean interval being twenty days after the onset of  symptoms. We had done nerve 
conduction studies in all four limbs as it has been shown to increase the diagnostic yield 
and helps in classifying the GBS patients.  
In this study, the bilateral median and ulnar nerves were stimulated at multiple points to 
assess for the presence of conduction block across the various segments and attempted to 
stimulate as  proximally as possible – Erb’s point stimulation. We also analysed the utility 
of other proximal segment stimulation – like H reflex, F waves, blink, facial and femoral 
and saphenous conductions.   
Motor nerve conduction studies  
Distal motor latency: - In our study, in the initial nerve conduction study done into the 
first week of illness, 40 - 60 % of nerves showed a prolonged distal motor latency [median 
(40 %), ulnar (60 %) and peroneal (45%)]. This is in comparison to the study by Gordon et 
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al,52 where in a retrospective analysis of 31 patients who presented in the first week of 
GBS, evaluation showed that the distal latency was prolonged in at least one nerve in 65 % 
of patients.(in multiple nerves in 45 % patients and in just one nerve in 19 %).  
In the second conduction study, while in two patients all motor nerves became in-
excitable, the percentage of nerves showing prolonged distal motor latency were median 
(45 %), ulnar (50 %), peroneal (45 %). Cornblath et al,90 in a study of 34 adult patients 
evaluated within four weeks of onset of illness detected that 57 % of nerves had a 
prolonged distal latency. 
Conduction Block: - 
 In the case of median nerve stimulation, it was detected that almost 30 % of nerves had 
evidence of conduction block (10 % definite and 20 % probable) in the first study when 
the results of stimulation at the wrist and elbow points were compared and another 5 % of 
nerves had definite block in the elbow to axilla segment. While in the second study, 30 % 
(15 % definite and 15 % probable) showed block only in the wrist to elbow segment.  
It has to be taken into account that in two patients (i.e. four median nerves) became in- 
excitable at the time of the second conductions. Gordon et al52 in a study of 31 patients  
reported an incidence of 13 % conduction block in the first week of GBS, however 
multiple segment stimulation was not done in this study . 
In the case of ulnar nerve stimulation, in the first study 40 % of nerves showed evidence of 
definite conduction block across the elbow segment in the first week. However, in the 
second study, the prevalence of the across elbow segment conduction block reduced to 25 
% (10 % definite and 15 % probable). In comparison, the analysis of the wrist to below 
elbow segment, showed that 25 % had evidence of conduction block (definite (20 %) + 
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probable (5 %)) in the first week while 15 % showed definite block in the second study. 
Since the majority of our patients with conduction block could move their arms freely at 
the time of the first electrophysiology study, it is unlikely that all the conduction blocks 
were due to nerve compression. 
 It has been reported by several investigators that the conduction abnormalities in GBS 
tend to be present at the distal nerve terminals, nerve roots and common entrapment sites 
of the peripheral nerves, where the blood-nerve barrier is thought to be relatively deficient 
or weak.55 Conduction blocks across the elbow segment were present in the majority of the 
patients with GBS when the examinations including the elbow segment were done. These 
findings were also detected in this study and showed that the conduction abnormalities at 
the common entrapment sites are a characteristic neurophysiologic feature observed in 
Guillain-Barre syndrome. One of our patients underwent a C8 root stimulation which again 
showed evidence of definite conduction block. 
In our study, the highest frequency of conduction block was detected in the ulnar nerves 
followed by the peroneal and median nerves. 
Ropper et al,92 in a study of 113 patients evaluated in the first three weeks of illness 
detected isolated proximal conduction block alone in 27 % of patients and proximal 
associated with a distal lesion in another 27 %.( However in this study by Ropper et al, the 
involvement of the F- waves was taken as suggestive of a proximal conduction block.)    
Cornblath et al,90 in a study of 112 adult nerves evaluated within the first four weeks of 
illness detected that 26 % had evidence of partial conduction block.(Here, partial 
conduction block was defined as >20 % reduction in the peak to peak amplitude or the 
negative peak area). 
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In a study of conduction block in Acute motor axonal neuropathy, Uncini et al 4 (done in 
two weeks of onset of illness) detected that twelve of the 18 patients (67%) had probable 
or definite conduction block. With respect to the forearm segments, conduction block was 
definite for one patient (6%) in the median nerve, probable for two patients (11%) in the 
median nerve and for three patients (16%) in the ulnar nerve. A common entrapment site 
(across the elbow segment of the ulnar nerve) showed definite conduction block in seven 
patients (39%) and probable conduction block in two patients (11%). In four of these seven 
patients, bilateral definite conduction blocks were observed. The time from disease onset 
in the first study of the 12 patients with AMAN who had conduction block (median 3 days, 
range 2–8 days) was similar to that in the six who did not (median 5 days, range 3–11 
days,). On sequential evaluation, rapid resolution was found in seven (58%) of the 12 
patients who had probable or definite conduction block.  
CMAP amplitude – 
In our study, there was a decrease in the CMAP amplitude in 35- 50 % of nerves in the 
first week. [median (35 %), ulnar (45 %) and peroneal (50 %)]. Gordon et al, 52 reported   
reduced CMAP amplitude in 71 % of patients in the first week. In the second conduction 
study, after excluding the four motor nerves which became in- excitable, the decrease in 
the CMAP amplitude was seen in median (40 %), ulnar (45 %) and peroneal (50 %).  
Proximal Conductions:- 
The analysis of the proximal conductions showed the findings of absent H- reflex response 
in 40 %, reduced amplitude in 60 % in the first conduction – i.e. 100 % of patients showed 
abnormality. This is similar to other studies reflecting these findings as one of the early 
abnormalities in GBS.  Gordon et al,52 reported that the H-reflex was absent in 30 patients 
(97%).   
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F- wave abnormalities, were picked up in the first conduction in around 55- 70 % of the 
nerves studied. (Ulnar -70 %, Median –55 % and peroneal 55 %). Gordon et al, 52 reported 
that F- waves were abnormal in 84% in the first week of illness.  
In the second conduction study while four motor nerves became in-excitable, isolated F- 
wave in-excitability was seen in 20 % of median and 10 % of nerves. Cornblath et al,90 in a 
study within four weeks of illness reported that 64 % of adult nerves (n= 86) had abnormal 
F -wave latencies. 
Blink Response:-  
The blink reflex study showed that only one patient (10 %) had abnormality in the first 
study while two patients (20 %) had abnormality in the second study. Kimura et al,93 had 
reported almost 50 % of patients with AIDP having blink reflex abnormality. Ropper et al 
92
 in 1990, in a study of 113 patients reported an abnormal blink reflex in 46 % of patients 
and all except one patient had facial weakness either symmetric or asymmetric.  
Sensory conductions :- 
The presence of sensory conduction abnormalities in the median nerves with relatively 
preserved sural SNAP s’ as described by several authors was also detected in this study. In 
the first conductions 20 % of patients had an abnormal median SNAP s’ with absolutely 
preserved sural SNAP s’, while this increased to 30 % in the second conduction. 
 Gordon et al,52 reported that SNAP in the upper extremity was of low amplitude or un-
recordable in 19 of 31 patients (61%) in the first week. Kuwabara et al 72, analysed the 
sensory conductions in 59 patients with GBS and detected abnormality in 86 % of AIDP 
(26 patients) and only in 6 % of AMAN ( 33 patients). 
Phrenic nerve conduction: - 
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Abnormalities of the phrenic nerve conductions (mostly unilateral) were seen in 50 % of 
the ten patients. However only two patients (20 %) had bilateral abnormalities and 
required mechanical ventilation. Bilateral abnormalities of the phrenic neve conductions 
can be early predictors of necessity for mechanical ventilation.94 
Sympathetic skin response: - 
The SSR response was absent in both the upper and lower limbs in five of the eight 
patients studied (60 %). Of these four were classifiable as AIDP and one as Axonal. 
Ropper et al 92 analysed the SSR in 23 patients had detected it to be absent in 4 (17 %) 
patients.  
 COMPARISON OF ELECTROPHYSIOLOGICAL CRITERIA: - 
 In our study, for the first electrophysiological test done in the first week of onset of 
symptoms  the sensitivity of the various criteria ( Set I to Set V ) in diagnosis of Guillain 
Barre  syndrome - AIDP - ranged between 30   and 100   % , with higher sensitivity of set I   
(Albers - 100  %) , set IV (Ho’s criteria- 90  %)  and set   V (Haddens- 100 %). It was 
noted that the sensitivity of the various sets of electrophysiological criteria was 
irrespective of the clinical presentation of GBS (i.e. pure motor, sensorimotor). The 
difference in the sensitivity of different electrophysiological criteria in the same patient 
population may be attributed to the difference in the requirements of number of 
demyelinating features, the number of nerves with demyelinating features and definition of 
conduction block. In set I, IV and V for fulfilling the criteria, requires the presence of only 
one demyelinating feature (prolonged distal latency, conduction block, dispersion, slowed 
conduction velocity, prolonged F-wave latency) in two nerves. However set II (Albers and 
Kelly) and set III (Cornblath) requires three of these demyelinating features in at least one 
to two nerves. 
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In an Indian study, by Kalita et al 57 (cross sectional study) of 51 GBS patients, of whom 
25 patients had presented in the first week of the onset of symptoms, the sensitivity was 88 
% with Albers criteria (Set I), 48 % with Albers and Kelly’s criteria (Set II), 32 % with 
Cornblath criteria (Set III) and 88 % with Ho’s criteria (Set IV). In the second 
electrophysiological test done in our study group it was found that the motor nerves were 
totally in-excitable in two patients and the sensitivity of the various criteria in the 
diagnosis of AIDP ranged from 50 %   to 80 %. The sensitivities were as follows 80 % ( 
set I), 80 %  ( set II), 50 % ( set III) ,80 % (  set IV), 80 % ( set V) . 
In the study by Uncini et al,4 a comparison was made between two serial electrodiagnostic 
tests done at least four weeks apart in the same group of 55 patients. At the first test the 
electrodiagnosis was identical with both criteria (Ho and Hadden) - 65 – 67 % of patients 
were classifiable as AIDP, 18 % were classifiable as Axonal GBS and 14 – 16 % was 
equivocal. However at follow up, there was a change in the classification in 24 % of 
patients. AIDP decreased to 58 %, axonal GBS increased to 38 % and equivocal patients 
decreased to 4 %.  It was noted that the majority of shifts were from AIDP and equivocal 
groups to axonal GBS. The main reason was that by serial recordings it was recognised 
that reversible conduction failure and length dependent compound muscle action potential 
amplitude reduction patterns were an expression of axonal pathology.  
LIMITATIONS OF THE STUDY:- 
The sample size is small, which is one of the main constraints of the study. 
In view of the above findings, this study with its limitations stresses the need for looking at 
longitudinal nerve conduction studies in a larger group of patients to further characterise 
better the incidence and pattern of electrophysiological subtypes and the change in the 
yield of the various published criteria. 
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CONCLUSIONS 
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1) The most common abnormality in the first electrophysiological study conducted in the 
first week of illness was the H- reflex abnormality (100 %). 
2) The yield of the other conduction parameters in the first conduction study were as 
follows:- 
       a) F- waves -   in- excitability and prolonged latency. (55 – 70 % of nerves) 
       b) Phrenic nerve conductions – 50 %  
       c) Conduction blocks   - 35 to 65 % of nerves. 
       d) Femoral nerve conductions’ - abnormal in 50 % of nerves studied. 
       e) Sensory conductions – abnormal in 15 to 20 % of upper limb nerves. 
3) Multiple segment stimulation helps in the detection of a higher percentage of 
conduction blocks in patient with GBS. The order of nerves with decreasing frequency of 
conduction blocks is as follows: - Ulnar (65%) > Peroneal (45%) > Median (35%). 
4) Sequential conduction in Guillain- Barre syndrome results in a change in the 
electrophysiological classification varying from 20 % to 50 % depending on the criteria 
used. 
5) Some of the motor nerves showing early conduction blocks (20%) showed evidence of  
axonal degeneration on serial conduction studies and this may indicate an 
electrophysiological feature of acute motor axonal neuropathy. 
6) Sensory conduction abnormalities are more common in the upper limb nerves than in 
the lower limbs (abnormal median / normal sural) and is statistically significant. 
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PATIENT INFORMATION AND INFORMED CONSENT 
 
 
I understand that the department of Neurological sciences is conducting a study to – 
 
(1) To evaluate the utility of multiple segment stimulation in nerve conduction 
studies and proximal conductions in patients with Guillain – Barre syndrome. 
(2) To determine whether multiple segment stimulation of nerves helps in the 
early detection of conduction block in patients in the first week of illness 
compared to routine conductions. 
 
Nerve conduction study is the standard diagnostic electrophysiological test for the 
diagnosis of the disease condition – Guillain- Barre syndrome with which I / (my 
patient) have been admitted in the hospital. I understand that in this study, the 
nerves will be stimulated at multiple points and studied for any abnormality.  
 
The study also involves collection of patient information – clinical data, findings 
of clinical examination and test reports done as part of regular clinical care. I 
understand that some of the tests done in connection with the study may directly 
benefit me / my patient whereas the other tests are likely to benefit other patients 
with the disease. 
 
I understand that my withdrawal from the study, at any time will not affect the 
treatment being given.  
 
Study Title:  Utility of multiple segment stimulation in nerve conduction studies 
in Guillain-Barre  syndrome 
 
Serial Number: _________ Subject’s Name: ________ 
Date of Birth / Age:_______ 
 
 
  
Please initial box  
(Subject) 
(i) I confirm that I have read/ have been explained to in my own language and have 
fully understood the information sheet for the above study and have had the 
opportunity to ask any questions that I had. [ ] 
(ii) I understand that my participation in the study is voluntary and that I am 
free to withdraw at any time, without giving any reason, without my medical care or 
legal rights being affected. [ ] 
 However, I understand that my identity will not be revealed in any information 
released to third parties or published. [ ] 
 (v) I agree to take part in the above study. [ ] 
 
Signature (or Thumb impression) of the Subject/Legally Acceptable  
 
Representative:_____________ 
Date: _____/_____/______ 
Signatory’s Name: _________________________________ 
 
 
Signature of the Investigator: ________________________ 
Date: _____/_____/______ 
 
 
Study Investigator’sName:       Dr Ajith.M / Dr.MathewAlexander 
_________________________ 
 
Signature of the Witness:  
 
___________________________ 
 
 
 
  
 
 
 
GLOSSARY 
 – coding for the data in the data sheet  
 
 
Sex – Female (1) ;  Male (2)  
Presence of Risk Factors –     Diarrhoea                            – Yes (1), No ( 0) 
- Upper respiratory infection – Yes (2) , No (0) 
-  Vaccination                        -  Yes (3) , No (0) 
- Viral Fever                          -  Yes (4) , No (0) 
 
     Facial and Bulbar weakness – 0 – absent,  
                                                     1  - mild involvement  
                                                     2 – moderate involvement. 
                                                     3 – severe weakness 
 
     Tone  -  1 – hypotonia , 2 – normal tone. 
 
     Power  (coding – modified MRC grading) 
      - 0 – 0 , 1 -  1, 2 – 2, 3 – 3 , 4 – 4, 5 – 4-,  5 – 4 , 6 – 4+,  7  - grade 5 
ANNEXURES  
DATA COLLECTION PROFORMA 
            GUILLAIN BARRE  SYND  
History                                                                 Date of diagnosis:: 
 
History   Days since onset of symptoms::     1 week  (       )              2   weeks   (        ) 
                                                                        3 weeks(        )             4  weeks    (        ) 
 
Preceding history    :-   Diarrhoea   (         )      URI    (       )    Vaccination   (         ) 
 
–    code        -       diarrhoea –yes – 1 ,          URI – yes - 2 ,            Vaccinat – yes - 3 
                                                No -  0                       No - 0                                 No -  0  
 
 
Co-morbidities : 
Hypertension      Diabetes      
Smoking       
IHD       Alcohol      
PVD       Obesity     
                               
Renal failure         
Native medication     
   
 
 
 
General Examination:     
Temp:   Pulse:-            reg/irreg  
Blood pressure:  lying:-   sitting :-     / 
 
Height:                       weight:                         BMI :  
 
CVS   Abdo:   Chest:   
                                                                                                                              
        
 
 
 
Name: 
 
Hospital Number: 
 
Dob:  Age: 
 
M/F     
Address: 
 
Telephone/E-mail: 
 
Seen by: 
 
Date:   Time: 
 
Serial number  
 
 Coding of Symptoms: 
 
Sensory  
Parasthesia  
        1 
.Symptoms limited to 
fingers or toes  
 
 
 
5-  trunk involvement 
       2  
.Symptoms extend to 
above knee with 
involvement of hands  
 
 
6 – Face involvement 
    3.  
Symptoms extend to 
above knee or elbow 
     4.  
Symptoms above knees 
or elbows/ trunk  
Sensory loss          1 
Symptoms limited to 
fingers or toes 
 
 
5- Trunkal involvement 
        2 
Symptoms extend to 
ankle or wrist 
 
 
6- face involvement 
    3 
Symptoms extend to 
knee or elbow 
       4 
Symptoms above knees 
or elbows 
pain          1 
.Symptoms limited to 
fingers or toes 
 
 
       2  
.Symptoms extend to 
ankle or wrist 
    3.  
Symptoms extend to 
knee or elbow 
     4.  
Symptoms above knees 
or elbows, or 
functionally disabling 
Type of pain          1  
Burning type  
       2 
Pricking type 
  
Motor         1 
Difficulty in hand grip  
        2 
Difficulty in combing, 
reaching up to shelf 
        3 
Difficulty in turning in 
bed  
   4  
Bulbar symptoms  
        5 
Difficulty in gripping 
foot wear, footwear 
slipping of with 
knowledge 
     6 
Twisting of ankle, 
buckling of knee  
      7 
Difficulty in getting up 
from squat  
     8 
Complete paralysis 
Bladder  
 
     0 
absent  
         
1-  Hesitancy   
 
2- urgency , urge 
incontinence 
 
3 – transientetention  
 
                 Symptoms                             Duration of symptoms: 
 Week 1  week 2  week 3  week 4  
Paresthesias      
Pain      
Pain type      
Sensory loss     
Motor      
Bladder      
 
  
 
 
  
 
   
 
 
 
 
 
 
 
 
 
HUGHES GRADING :-   --         ------ 
 
GRADE    0  :-    Normal 
GRADE    1  :-    minimal signs and symptoms , able to run 
GRADE    2  :-    ambulates independently 
GRADE   3   :-    able to walk 5 metres with aid 
GRADE   4   :-    bed bound 
GRADE   5   :-    requires mechanical ventilation  
GRADE   6  :-    dead 
 
  
            
   
            
            
 
Neurological examination: 
Cranial Nerves                                                                              0 = normal , 1 = abnormal  
Cranial nerves week 1 week 2 week 3 week 4 
Fundus      
EOM      
Trigeminal      
Facial      
 9, 10     
Sternomastoid      
Tongue      
 
    Motor Examination  
 
       Bulk and Tone                                 
WASTING week 1 week 2 week 3 week 4 
EDB     
Tib  Ant     
Gastronemius     
Quadriceps     
Hand muscles     
Tone     
                                                                                                          
WASTING :-    yes – 1 , no – 2 
 
TONE         :-  0 = normal,  1 = decreased , 2 -   increased  
                 Motor  Examination  
 
                                                                                                          
        Power                                                                                     
 
week 1 week 2 weeek 3 week4 
Power  R L R L R L R L 
Neck flx         
Neck ext         
Trunk          
Should Ab         
Should Add          
Elbow Flx         
Elbow Ext          
Wrist Flx          
Wrist Ext          
Hip Flx          
Hip Ext          
Knee Flex          
Knee Ext          
Dorsiflx          
Plantarflx         
                                                                                                                                                                         MRC Grading 
0  No movement 
1  Flicker 
2  Movement not against gravity 
3 Movement against gravity 
4 Against resistance 
5 Normal    
 
 
 
 
 
Reflexes  
 
 
week 1 week 2 week 3 week 4 
Reflexes  R L R L R L R L 
Biceps          
Brachiorad          
Triceps          
Knee          
Ankle          
Sup abd         
plantar         
 
                                                                                                                                                                                Reflex Grading 
 0 Absent 
 +/-  Present with reinforcement 
+ Decreased 
 ++ Normal 
 +++ Increased 
 C With clonus 
 
 
  
 
 
        
 
                                                                                                                             
 Electrophysiology  
 week1 week2 week3  week4  
NCV      
EMG      
phrenic     
Con.bloc     
                                                                                                               0 = normal, 1 = abnormal 
        
Type of Neuropathy :  AIDP /AMSAN/ AMAN  
 
 
 
CSF – TC  
            DC 
            SUGAR 
            PROTEIN 
             
 
 
BBVS  :- 
 
 
 
Investigations  
    
Hb   Urine 
porphobilinogen 
 
TC  Ca  
DC   Phosp  
Platelets  Na  
ESR  K  
AC  Total protein  
PC     
Creat    
    
    
                                                                                                                   
